ARCHIVES

TGen’s Trent To Lead Van Andel Institute

This article is from The Cancer Letter archive.

Vol. 35 No. 06 | February 13, 2009

Download PDF Visit The Full Archive

Related Articles

Most of NCI’s $60 Million Increase In FY95 will fund Mandatory Raise In Prevention

October 14, 1994

NKTR-102 Shows 29 Percent Response in Phase II Study

September 30, 2011

ODAC Recommends Fludarabine Approval for Refractory CLL

September 21, 1990

ASCO Urges Increase In Research Funding, Removal of Barriers For Trial Participation

January 23, 2009

FDA Puts Clinical Hold On Gene Therapy Trials

January 24, 2003

NCI Establishes New Program Project Grant Guidelines.

January 13, 2006